Pfizer Acquires a GLP-1 Pipeline and Revives FOMO Corporate Strategy Discussing Pfizer's savvy acquisition of Metsera and critiquing the GLP-1 'gap analysis' many outsiders promote as a reason all the Big Pharmas will be in GLP-1 On Monday, Pfizer PFE 0.00% announced it is acquiring Metsera MTSR 0.00% and its obesity pipeline
Congress could change this in the future, and some organizations are working to get it passed
A limited number of preclinical studies suggest that berberine may modestly increase endogenous GLP-1 secretion from intestinal L-cells, potentially through effects on gut microbiota or direct stimulation of enteroendocrine cells
However, it is important to keep track of the changes to your side effects and get medical attention if they worsen
Additionally, the rise of e-prescriptions, telehealth integration, and subscription-based refill models have further supported the transition to digital pharmacy channels
"We recommend that you follow the proper dosing guidelines to prevent any issues." Here are a few potential side effects: Hormone effects unclear